Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_2
3
27%
Ph phase_1
8
73%

Phase Distribution

8

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
8(72.7%)
Phase 2Efficacy & side effects
3(27.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(10)
Terminated(1)

Detailed Status

Completed10
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
90.9%
Most Advanced
Phase 2

Trials by Phase

Phase 18 (72.7%)
Phase 23 (27.3%)

Trials by Status

terminated19%
completed1091%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11